SP7 Knockout U2OS Cell Line
Cat.No.:
EDC07588
Species:
Human
Cell Name:
U2OS
Gene:
SP7
Gene ID:
121340
Size:
1×10⁶cells
SP7 Knockout U2OS Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07588 |
|---|---|
| Product Name | SP7 Knockout U2OS Cell Line |
| Species | Human |
| Cell Line | U2OS |
| Cellosaurus ID | CVCL_0042 |
| Gene ID | |
| Cell Line Synonyms | U-2 OS, U-2OS, U-2-OS, U2-OS, U20-S, U20S, 2T |
| Gene | SP7 |
| Summary |
This gene encodes a member of the Sp subfamily of Sp/XKLF transcription factors. Sp family proteins are sequence-specific DNA-binding proteins characterized by an amino-terminal trans-activation domain and three carboxy-terminal zinc finger motifs. This protein is a bone specific transcription factor and is required for osteoblast differentiation and bone formation.[provided by RefSeq, Jul 2010]
|
| Digestion Time | ~2 min |
| Associated Diseases | Osteosarcoma |
| Morphology | Adherent |
| Passage Ratio | 1:3 |
| Complete Culture Medium | mcCoy5A+10% FBS |
| Freezing Medium | 95% complete culture medium + 5% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: U2OS | STR Info (Cell bank) Cell Line: U2OS | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 13 | 13 | ||
| D1S1656 | 15 | 17.3 | 16 | 17.3 |
| D2S1338 | 20 | 24 | 20 | 24 |
| D3S1358 | 16 | 16 | ||
| D5S818 | 11 | 11 | ||
| D6S1043 | 11 | 11 | ||
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D12S391 | 19 | 20 | 19 | 20 |
| D13S317 | 13 | 13 | ||
| D16S539 | 11 | 12 | 11 | 12 |
| D18S51 | 14 | 14 | ||
| D19S433 | 15 | 15 | ||
| D21S11 | 31 | 31 | ||
| FGA | 20 | 20 | ||
| Penta D | 9 | 9 | ||
| Penta E | 10 | 13 | 10 | 13 |
| TH01 | 6 | 9.3 | 6 | 9.3 |
| TPOX | 11 | 12 | 11 | 12 |
| VWA | 14 | 18 | 14 | 18 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SP7 function, SP7 Knockout U2OS Cell Line or SP7 overexpression U2OS Cell Line?
The choice depends on whether you are studying SP7's role as a master osteoblast transcription factor or its therapeutic implications in bone disease and osteosarcoma. The Knockout line is appropriate for asking whether SP7 is required for osteoblast-specific gene programs — particularly relevant in U2OS, which retains osteogenic gene expression features as an osteosarcoma cell line. Overexpression is useful for testing whether elevated SP7 is sufficient to drive osteoblast differentiation programs or for studying SP7 transactivation activity.
For bone biology research, the EDITGENE SP7 Knockout in U2OS is particularly informative — U2OS expresses many osteoblast lineage markers and supports the assessment of SP7-dependent gene programs in an osteosarcoma genetic background. Rescue with wild-type or DNA-binding-deficient SP7 enables structure-function dissection. SP7 mutations cause osteogenesis imperfecta type XII — disease variant rescue enables genotype-phenotype correlation studies.
What are the application scenarios for this model?
Primary applications:
• Osteoblast gene program analysis: expression analysis of SP7 target genes (COL1A1, BGLAP/osteocalcin, IBSP, SPP1) in U2OS following SP7 loss.
• ChIP-seq for SP7 occupancy: mapping SP7 binding sites at osteoblast gene promoters; the knockout serves as a critical signal specificity control.
• Osteogenesis imperfecta modeling: rescue with disease-associated SP7 mutations enables genotype-function studies for type XII osteogenesis imperfecta.
• Osteosarcoma biology: proliferation and differentiation phenotype assays in the U2OS osteosarcoma background.
EDITGENE recommends this model for researchers investigating osteoblast biology, SP7 transcription factor function, and osteogenesis imperfecta mechanisms.
Is this SP7 Knockout U2OS Cell Line compatible with overexpression rescue experiments?
Yes. SP7 rescue experiments require attention to its zinc finger DNA-binding and proline-rich activation regions:
• Construct design: use a codon-modified SP7 sequence with a small N- or C-terminal tag (FLAG, HA). SP7 contains three C2H2 zinc fingers in the DNA-binding region and a proline-rich transactivation region — both should be preserved.
• DNA-binding-deficient rescue: zinc finger mutations (e.g., key cysteine substitutions) abolish GC-box binding and serve as the standard specificity control.
• Disease mutation rescue: SP7 mutations causing osteogenesis imperfecta type XII can be introduced for genotype-phenotype correlation studies.
• Functional readout: rescue should restore osteoblast target gene expression (COL1A1, BGLAP) and SP7 chromatin occupancy.
U2OS transduces efficiently with lentivirus and supports stable rescue line generation; its flat morphology aids imaging-based analyses.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download